Instituto Nacional de Salud del Niño

Institution (Healthcare)

Homepage ROR

Also Known As

Hospital del Niño, Instituto Nacional de Salud del Niño

2.3K

Publications

33.7K

Citations

134

Authors

310

Concepts

About

Instituto Nacional de Salud del Niño is a healthcare institution in Lima, Peru known for medicine, public health, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	9	12	398
2	Education	5	6	162
3	Engineering	3	3	223
4	Business	1	1	113
5	Language Studies	1	1	24

Instituto Nacional de Salud del Niño

2.3K

Publications

33.7K

Citations

Page 1

	Year	Citations
EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria Seza Özen, Angela Pistorio, S. M. Iusan, Annals of the Rheumatic Diseases	2010	1.4K
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma Christine Léauté-Labrèze, Peter H. Hoeger, J. Mazereeuw‐Hautier, New England Journal of Medicine	2015	745
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis Nicolino Ruperto, Hermine I. Brunner, Pierre Quartier, New England Journal of Medicine	2012	689
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial Nicolino Ruperto, Daniel J. Lovell, Pierre Quartier, The Lancet Rheumatoid DisorderRheumatologyJuvenile Idiopathic ArthritisChildhood ArthritisPediatrics	2008	543
Effects of EI Niño and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children William Checkley, Leonardo D. Epstein, Robert H. Gilman, The Lancet MedicineGlobal HealthEnvironmental HealthInternational HealthGastroenterology	2000	412
Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years Barbara Knorr, Luis Miguel Franchi, Hans Bisgaard, PEDIATRICS	2001	391
Every Newborn: health-systems bottlenecks and strategies to accelerate scale-up in countries Kim Dickson, Aline Simen-Kapeu, Mary Kinney, The Lancet Health SystemsNeonatologyComparative Health SystemsHealth PolicyGlobal Health Program	2014	352
Risk factors for burns in children: crowding, poverty, and poor maternal education João Delgado, M E Ramírez-Cardich, Robert H. Gilman, Injury Prevention	2002	261
Long‐term safety and efficacy of abatacept in children with juvenile idiopathic arthritis Nicolino Ruperto, Daniel J. Lovell, Pierre Quartier, Arthritis & Rheumatism	2010	228
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial Jordana B. Cohen, Thomas C. Hanff, Preethi William, The Lancet Respiratory Medicine Open-label TrialHypertensionCardiovascular DiseaseAntihypertensive TherapyClinical Trials	2021	221

Page 1